articleThe LancetSep 1, 2003Closed access

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Duke University Hospital · Duke Medical Center · +9 more institutions

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

1,679
total citations
FWCI
67.70
Percentile
100%
References
19
Citations per year

Authors

9

Topics & keywords

Keywords
  • Candesartan
  • Cardiology
  • Medicine
  • Heart failure
  • Internal medicine
  • Charm (quantum number)
  • Angiotensin-converting enzyme
  • Angiotensin II
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding